SCHEMBL4359852

SCHEMBL4359852

O=C1OC(=O)[C@@H]2CC12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14685237 1.00 KDM4E (0.39)
SCHEMBL615001 1.00 KDM4E (0.39)
SCHEMBL2495557 1.00
SCHEMBL14669163 1.00
SCHEMBL13444708 1.00 KDM4E (0.39)
SCHEMBL24843176 1.00 KDM4E (0.39)
SCHEMBL16360071 1.00 KDM4E (0.39)
SCHEMBL14424191 1.00 KDM4E (0.39)
SCHEMBL15498544 1.00 KDM4E (0.39)
SCHEMBL22300612 0.91 KDM4E (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120116064-A1 HYBRID LIPID COMPOUNDS BASED ON PENTAERYTHRITOL, INTERMEDIATES, PREPARATION METHODS AND USE THEREOF HARBIN INSTITUTE OF TECHNOLOGY (CN) 2012-05-10 US disclosed
WO-2009023201-A1 RIGID DERIVATIVES OF TRIPTOLIDE AS ANTICANCER, IMMUNE SUPPRESSANT, ANTI-FIBROSIS, AND CNS PROTECTANT AGENTS MYELORX LLC (US) 2009-02-19 WO disclosed